ad image

Allergies

1 / 1
Applying Revolutionary Thinking to Autoimmune and Allergic Diseases
Immunology

Applying Revolutionary Thinking to Autoimmune and Allergic Diseases

Jonathan Rigby

Revolo Biotherapeutics

PAO-04-22-R250-66Apr 19, 2022
Revolo Biotherapeutics
Rebranding

Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases

Revolo Biotherapeutics

PR-M11-20-041Mar 05, 2021
Developing a Microbiome-Based Treatment for Food Allergies
Allergies

Developing a Microbiome-Based Treatment for Food Allergies

John Colson, Ph.D.

ClostraBio

PAP-Q3-19-CL-008Oct 28, 2019
Pricing Concerns Already Raised About Development Treatments for Peanut Allergies
Drug Pricing

Pricing Concerns Already Raised About Development Treatments for Peanut Allergies

Nice Insight

PAO-M08-19-NI-003Aug 01, 2019
U.S. Food & Drug Administration
FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's new consideration of labeling for sesame allergies

U.S. Food & Drug Administration

PR-M10-18-NI-109Oct 31, 2018
Genentech
FDA Approval

FDA Grants Breakthrough Therapy Designation for Xolair(Omalizumab) for Food Allergies

Genentech

PR-M09-18-NI-005Sep 04, 2018
1 / 1